REGENERON PHARMACEUTICALS, INC.

A biotech firm inventing, developing, and commercializing medicines for serious diseases.

REGN | US

Overview

Corporate Details

ISIN(s):: US75886F1075
LEI:
Country:: United States of America
Address:: 777 OLD SAW MILL RIVER ROAD, 10591 TARRYTOWN
Website:: https://www.regeneron.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Regeneron Pharmaceuticals, Inc. is a leading biotechnology company that invents, develops, manufactures, and commercializes medicines for people with serious diseases. Founded in 1988, the company leverages its scientific and technological capabilities to produce a portfolio of treatments and a pipeline of product candidates. Its research and development efforts span multiple therapeutic areas, including ophthalmology, oncology, cardiovascular and metabolic diseases, and inflammatory conditions. Regeneron focuses on turning cutting-edge science into transformative medicines, with active programs in areas such as genetic medicines (including CRISPR), cancer-fighting immunotherapies, and treatments for obesity.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all REGENERON PHARMACEUTICALS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for REGENERON PHARMACEUTICALS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for REGENERON PHARMACEUTICALS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
BioLineRx Ltd. A biopharmaceutical firm developing and commercializing therapies for oncology and rare diseases.	United States of America	BLRX
BIOMARIN PHARMACEUTICAL INC Develops and commercializes therapies for rare, life-threatening genetic diseases.	United States of America	BMRN
BioMaxima S.A. Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.	Poland	BMX
Biomea Fusion, Inc. Develops oral small molecules for metabolic diseases like diabetes and for specific cancers.	United States of America	BMEA
BIOMERICA INC Develops diagnostic tests for GI, inflammatory diseases, and diabetes for lab and at-home use.	United States of America	BMRA
bioMérieux Provides in vitro diagnostic solutions for clinical and industrial microbiology.	France	BIM
BiomX Inc. Develops phage therapies to target harmful bacteria in chronic diseases like cystic fibrosis.	United States of America	PHGE
BioNTech SE Pioneering mRNA immunotherapies and vaccines to combat cancer and infectious diseases.	United States of America	BNTX
BioPorto IVD company developing NGAL biomarkers for early acute kidney injury (AKI) risk assessment.	Denmark	BIOPOR
BioRestorative Therapies, Inc. A clinical-stage company developing stem cell therapies for pain, metabolic disorders, and aesthetics.	United States of America	BRTX